Fresenius Kabi at a glance
Fresenius Kabi is the leader in Infusion Therapy and Clinical Nutrition in Europe and in its most important countries of Latin America and Asia Pacific.
We are focused on the therapy and care of critically and chronically ill patients in and outside the hospital.
Fresenius Kabi has around 17,000 employees worldwide and a global network of more than 50 sales organizations and around 45 productions sites. We achieved sales of € 2,030 million and an operating income (EBIT) of € 332 million in 2007.
Fresenius Kabi AG is a 100% subsidiary of the health care group Fresenius SE.